A randomised placebo-controlled trial of Oxpentifylline (Trental) in erythropoietin-resistant anaemia (ERA) in chronic kidney disease (2007–2012)

Abstract:
That Oxpentifylline (Trental) administration will effectively treat erythropoietin or darbepoietin-resistant anaemia in chronic kidney disease patients.
Grant type:
The Roche Foundation for Anemia Research
Researchers:
  • Academic Title-Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
  • Academic Title-Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
Funded by:
The Roche Foundation For Anemia Research